跳至主要内容
临床试验/NCT06535503
NCT06535503招募中不适用

Clinical Characteristics and Outcomes Among ST-elevation Myocardial Infarction (STEMI) Patients with Cardiogenic Shock At Abu Dhabi City

Abu Dhabi Health Services Company2 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2024年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
400
试验地点
2
主要终点
Incidence of CS-complicated AMI events

研究概览

简要总结

A retrospective study on the clinical characteristics and treatment outcomes of patients admitted with ST-elevation Myocardial Infarction (STEMI) complicated with cardiogenic shock (CS) during admission or CS development during their hospital stay for two tertiary hospitals in Abu Dhabi, UAE, from 2020-2024.

详细描述

Cardiovascular disease (CVD) accounts for 40% of mortality in the UAE, which is higher than the global average. Long-term trends, incidence studies, and best practice guidance on Cardiogenic Shock (CS) with ST-elevation Myocardial infarction (STEMI) in the United Arab Emirates (UAE) and the Gulf Cooperation Council (GCC) are limited.

Through this retrospective study, investigators aim to identify treatment modalities and trends, hospitalization events, and patient demographics and comorbidities which lead to participant recovery or mortality in Sheikh Khalifa Medical City (SKMC) and Sheikh Shakhbout Medical City (SSMC) tertiary hospitals for patients admitted with STEMI and CS or developed CS after hospitalization with STEMI during January 2020-January 2024.[200-400 participants]. Data will be collected from eligible patients' electronic medical records (EMR).

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age more than
  • STEMI complicated by cardiogenic shock.
  • Were hospitalized or treated at SSMC or SKMC for STEMI complicated by cardiogenic shock.
  • Patient admitted between January 2019 to March 2024.

排除标准

  • Age less than
  • Shock patient not related to Myocardial infarction.
  • NSTEMI-related cardiogenic shock.
  • Patients who were not treated at SSMC or SKMC for the STEMI complicated by cardiogenic shock.
  • Patient not admitted between January 2019 to March 2024.

结局指标

主要结局

Incidence of CS-complicated AMI events

时间窗: 5 years

The incidence of CS-complicated AMI events will show an increase over the years because of advanced diagnostic modalities and a clearer definition of CS.

Analyze STEMI patient with CS disease profile

时间窗: 5 years

Incidence of Morbidity

Analyze treatment outcomes in the targeted population as per the patient profile

时间窗: 5 years

Incidence of Mortality

Analyze treatment outcomes

时间窗: 5 years

% of patients who were discharged

次要结局

未报告次要终点

研究者

发起方
Abu Dhabi Health Services Company
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Babiker Mohamed Babiker Elsiraj

Principal Investigator, Cardiology Specialist/Fellow at Sheikh Shakhbout Medical City

Abu Dhabi Health Services Company

研究点 (2)

Loading locations...

相似试验